Athenex Inc

NASDAQ:ATNX   3:59:51 PM EDT
2.75
+0.12 (+4.56%)
Products

Athenex Announces FDA Approval of Klisyri for the Treatment of Actinic Keratosis on the Face or Scalp

Published: 12/15/2020 13:56 GMT
Athenex Inc (ATNX) - Athenex Announces FDA Approval of Klisyri® (tirbanibulin) for the Treatment of Actinic Keratosis on the Face Or Scalp.
Athenex Inc - Klisyri Will Be Launched in Partnership With Almirall in U.S. During Q1 Of.